nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLCO1B1—breast cancer	0.527	1	CbGaD
Acetylcysteine—ACY1—skin of body—breast cancer	0.00312	0.0462	CbGeAlD
Acetylcysteine—ACY1—female reproductive system—breast cancer	0.00243	0.0361	CbGeAlD
Acetylcysteine—ACY1—adrenal gland—breast cancer	0.00238	0.0352	CbGeAlD
Acetylcysteine—IKBKB—nipple—breast cancer	0.00228	0.0338	CbGeAlD
Acetylcysteine—CHUK—epithelium—breast cancer	0.00226	0.0335	CbGeAlD
Acetylcysteine—GSS—nipple—breast cancer	0.00224	0.0332	CbGeAlD
Acetylcysteine—CHUK—skin of body—breast cancer	0.00215	0.0319	CbGeAlD
Acetylcysteine—ACY1—endocrine gland—breast cancer	0.00206	0.0305	CbGeAlD
Acetylcysteine—SLCO1B1—mammary gland—breast cancer	0.00199	0.0295	CbGeAlD
Acetylcysteine—IKBKB—embryo—breast cancer	0.00188	0.0279	CbGeAlD
Acetylcysteine—CHUK—adipose tissue—breast cancer	0.00183	0.0271	CbGeAlD
Acetylcysteine—CHUK—female reproductive system—breast cancer	0.00168	0.0249	CbGeAlD
Acetylcysteine—CHUK—adrenal gland—breast cancer	0.00164	0.0243	CbGeAlD
Acetylcysteine—CHUK—female gonad—breast cancer	0.00153	0.0226	CbGeAlD
Acetylcysteine—SLC7A11—adipose tissue—breast cancer	0.00151	0.0223	CbGeAlD
Acetylcysteine—IKBKB—skin of body—breast cancer	0.00146	0.0217	CbGeAlD
Acetylcysteine—GSS—skin of body—breast cancer	0.00144	0.0213	CbGeAlD
Acetylcysteine—CHUK—endocrine gland—breast cancer	0.00142	0.0211	CbGeAlD
Acetylcysteine—SLC7A11—female reproductive system—breast cancer	0.00138	0.0205	CbGeAlD
Acetylcysteine—IKBKB—endometrium—breast cancer	0.00138	0.0204	CbGeAlD
Acetylcysteine—GSS—endometrium—breast cancer	0.00135	0.02	CbGeAlD
Acetylcysteine—SLC7A11—Betamethasone—Fluoxymesterone—breast cancer	0.00131	0.5	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Fluoxymesterone—breast cancer	0.00131	0.5	CbGdCrCtD
Acetylcysteine—GRIN1—endocrine gland—breast cancer	0.0013	0.0193	CbGeAlD
Acetylcysteine—IKBKB—uterus—breast cancer	0.00127	0.0188	CbGeAlD
Acetylcysteine—SLC7A11—female gonad—breast cancer	0.00126	0.0186	CbGeAlD
Acetylcysteine—GRIN2A—adrenal gland—breast cancer	0.00125	0.0185	CbGeAlD
Acetylcysteine—IKBKB—pituitary gland—breast cancer	0.00125	0.0185	CbGeAlD
Acetylcysteine—GSS—uterus—breast cancer	0.00125	0.0185	CbGeAlD
Acetylcysteine—IKBKB—adipose tissue—breast cancer	0.00124	0.0184	CbGeAlD
Acetylcysteine—GRIN2B—endocrine gland—breast cancer	0.00124	0.0184	CbGeAlD
Acetylcysteine—GSS—pituitary gland—breast cancer	0.00122	0.0181	CbGeAlD
Acetylcysteine—GSS—adipose tissue—breast cancer	0.00122	0.0181	CbGeAlD
Acetylcysteine—SLC7A11—endocrine gland—breast cancer	0.00117	0.0173	CbGeAlD
Acetylcysteine—IKBKB—female reproductive system—breast cancer	0.00114	0.0169	CbGeAlD
Acetylcysteine—GSS—female reproductive system—breast cancer	0.00112	0.0166	CbGeAlD
Acetylcysteine—IKBKB—adrenal gland—breast cancer	0.00111	0.0165	CbGeAlD
Acetylcysteine—GSS—adrenal gland—breast cancer	0.00109	0.0162	CbGeAlD
Acetylcysteine—GRIN2A—endocrine gland—breast cancer	0.00108	0.0161	CbGeAlD
Acetylcysteine—GSS—bone marrow—breast cancer	0.00106	0.0157	CbGeAlD
Acetylcysteine—IKBKB—female gonad—breast cancer	0.00104	0.0154	CbGeAlD
Acetylcysteine—GSS—female gonad—breast cancer	0.00102	0.0151	CbGeAlD
Acetylcysteine—CHUK—lymph node—breast cancer	0.000983	0.0146	CbGeAlD
Acetylcysteine—IKBKB—endocrine gland—breast cancer	0.000967	0.0143	CbGeAlD
Acetylcysteine—GSS—endocrine gland—breast cancer	0.000949	0.0141	CbGeAlD
Acetylcysteine—SLCO1B1—female reproductive system—breast cancer	0.000824	0.0122	CbGeAlD
Acetylcysteine—SLCO1B1—endocrine gland—breast cancer	0.000697	0.0103	CbGeAlD
Acetylcysteine—IKBKB—lymph node—breast cancer	0.000668	0.0099	CbGeAlD
Acetylcysteine—GSS—lymph node—breast cancer	0.000656	0.00971	CbGeAlD
Acetylcysteine—Dizziness—Goserelin—breast cancer	0.000159	0.000917	CcSEcCtD
Acetylcysteine—Hypotension—Fluorouracil—breast cancer	0.000159	0.000916	CcSEcCtD
Acetylcysteine—Rash—Tamoxifen—breast cancer	0.000159	0.000915	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vinorelbine—breast cancer	0.000159	0.000915	CcSEcCtD
Acetylcysteine—Dermatitis—Tamoxifen—breast cancer	0.000159	0.000914	CcSEcCtD
Acetylcysteine—Dyspnoea—Mitoxantrone—breast cancer	0.000158	0.000913	CcSEcCtD
Acetylcysteine—Dyspnoea—Irinotecan—breast cancer	0.000158	0.000913	CcSEcCtD
Acetylcysteine—Somnolence—Mitoxantrone—breast cancer	0.000158	0.00091	CcSEcCtD
Acetylcysteine—Somnolence—Irinotecan—breast cancer	0.000158	0.00091	CcSEcCtD
Acetylcysteine—Angiopathy—Docetaxel—breast cancer	0.000157	0.000904	CcSEcCtD
Acetylcysteine—Vomiting—Melphalan—breast cancer	0.000157	0.000903	CcSEcCtD
Acetylcysteine—Dyspepsia—Irinotecan—breast cancer	0.000156	0.000901	CcSEcCtD
Acetylcysteine—Dyspepsia—Mitoxantrone—breast cancer	0.000156	0.000901	CcSEcCtD
Acetylcysteine—Immune system disorder—Docetaxel—breast cancer	0.000156	0.0009	CcSEcCtD
Acetylcysteine—Loss of consciousness—Paclitaxel—breast cancer	0.000156	0.000899	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Docetaxel—breast cancer	0.000156	0.000898	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—breast cancer	0.000156	0.000897	CcSEcCtD
Acetylcysteine—Rash—Melphalan—breast cancer	0.000155	0.000896	CcSEcCtD
Acetylcysteine—Cardiac disorder—Capecitabine—breast cancer	0.000155	0.000895	CcSEcCtD
Acetylcysteine—Flushing—Capecitabine—breast cancer	0.000155	0.000895	CcSEcCtD
Acetylcysteine—Dermatitis—Melphalan—breast cancer	0.000155	0.000895	CcSEcCtD
Acetylcysteine—Cough—Paclitaxel—breast cancer	0.000155	0.000893	CcSEcCtD
Acetylcysteine—Dyspnoea—Gemcitabine—breast cancer	0.000154	0.000889	CcSEcCtD
Acetylcysteine—Nausea—Vinblastine—breast cancer	0.000154	0.000887	CcSEcCtD
Acetylcysteine—Somnolence—Gemcitabine—breast cancer	0.000154	0.000887	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Irinotecan—breast cancer	0.000153	0.000884	CcSEcCtD
Acetylcysteine—Vomiting—Goserelin—breast cancer	0.000153	0.000881	CcSEcCtD
Acetylcysteine—Pruritus—Vinorelbine—breast cancer	0.000152	0.000878	CcSEcCtD
Acetylcysteine—Angiopathy—Capecitabine—breast cancer	0.000152	0.000875	CcSEcCtD
Acetylcysteine—Dyspnoea—Fluorouracil—breast cancer	0.000152	0.000874	CcSEcCtD
Acetylcysteine—Rash—Goserelin—breast cancer	0.000152	0.000874	CcSEcCtD
Acetylcysteine—Hypersensitivity—Thiotepa—breast cancer	0.000151	0.000873	CcSEcCtD
Acetylcysteine—Dermatitis—Goserelin—breast cancer	0.000151	0.000873	CcSEcCtD
Acetylcysteine—Somnolence—Fluorouracil—breast cancer	0.000151	0.000872	CcSEcCtD
Acetylcysteine—Immune system disorder—Capecitabine—breast cancer	0.000151	0.000871	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Capecitabine—breast cancer	0.000151	0.000869	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—breast cancer	0.000151	0.000869	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—breast cancer	0.00015	0.000868	CcSEcCtD
Acetylcysteine—Erythema—Docetaxel—breast cancer	0.00015	0.000867	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.00015	0.000865	CcSEcCtD
Acetylcysteine—Dyspepsia—Fluorouracil—breast cancer	0.00015	0.000863	CcSEcCtD
Acetylcysteine—Nausea—Tamoxifen—breast cancer	0.000149	0.000862	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000149	0.000861	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000147	0.000847	CcSEcCtD
Acetylcysteine—Nausea—Melphalan—breast cancer	0.000146	0.000844	CcSEcCtD
Acetylcysteine—Erythema—Capecitabine—breast cancer	0.000146	0.00084	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—breast cancer	0.000146	0.000839	CcSEcCtD
Acetylcysteine—Pruritus—Thiotepa—breast cancer	0.000145	0.000839	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Paclitaxel—breast cancer	0.000145	0.000835	CcSEcCtD
Acetylcysteine—Oedema—Paclitaxel—breast cancer	0.000145	0.000835	CcSEcCtD
Acetylcysteine—Nausea—Goserelin—breast cancer	0.000143	0.000823	CcSEcCtD
Acetylcysteine—Shock—Paclitaxel—breast cancer	0.000142	0.000822	CcSEcCtD
Acetylcysteine—Dizziness—Vinorelbine—breast cancer	0.000142	0.000821	CcSEcCtD
Acetylcysteine—Tachycardia—Paclitaxel—breast cancer	0.000141	0.000815	CcSEcCtD
Acetylcysteine—Urticaria—Mitoxantrone—breast cancer	0.000141	0.000813	CcSEcCtD
Acetylcysteine—Skin disorder—Paclitaxel—breast cancer	0.000141	0.000811	CcSEcCtD
Acetylcysteine—Body temperature increased—Mitoxantrone—breast cancer	0.00014	0.000809	CcSEcCtD
Acetylcysteine—Body temperature increased—Irinotecan—breast cancer	0.00014	0.000809	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Paclitaxel—breast cancer	0.00014	0.000807	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—breast cancer	0.000139	0.000804	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—breast cancer	0.000139	0.0008	CcSEcCtD
Acetylcysteine—Vomiting—Vinorelbine—breast cancer	0.000137	0.000789	CcSEcCtD
Acetylcysteine—Body temperature increased—Gemcitabine—breast cancer	0.000137	0.000788	CcSEcCtD
Acetylcysteine—Dizziness—Thiotepa—breast cancer	0.000136	0.000784	CcSEcCtD
Acetylcysteine—Rash—Vinorelbine—breast cancer	0.000136	0.000783	CcSEcCtD
Acetylcysteine—Dermatitis—Vinorelbine—breast cancer	0.000136	0.000782	CcSEcCtD
Acetylcysteine—Hypotension—Paclitaxel—breast cancer	0.000135	0.00078	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—breast cancer	0.000135	0.00078	CcSEcCtD
Acetylcysteine—Urticaria—Fluorouracil—breast cancer	0.000135	0.000779	CcSEcCtD
Acetylcysteine—Syncope—Docetaxel—breast cancer	0.000135	0.000778	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—breast cancer	0.000135	0.000777	CcSEcCtD
Acetylcysteine—Body temperature increased—Fluorouracil—breast cancer	0.000134	0.000775	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—breast cancer	0.000133	0.000767	CcSEcCtD
Acetylcysteine—Loss of consciousness—Docetaxel—breast cancer	0.000132	0.000762	CcSEcCtD
Acetylcysteine—Cough—Docetaxel—breast cancer	0.000131	0.000757	CcSEcCtD
Acetylcysteine—Hypersensitivity—Mitoxantrone—breast cancer	0.000131	0.000754	CcSEcCtD
Acetylcysteine—Hypersensitivity—Irinotecan—breast cancer	0.000131	0.000754	CcSEcCtD
Acetylcysteine—Vomiting—Thiotepa—breast cancer	0.000131	0.000754	CcSEcCtD
Acetylcysteine—Syncope—Capecitabine—breast cancer	0.000131	0.000753	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—breast cancer	0.00013	0.000748	CcSEcCtD
Acetylcysteine—Rash—Thiotepa—breast cancer	0.00013	0.000748	CcSEcCtD
Acetylcysteine—Dermatitis—Thiotepa—breast cancer	0.00013	0.000747	CcSEcCtD
Acetylcysteine—Dyspnoea—Paclitaxel—breast cancer	0.000129	0.000744	CcSEcCtD
Acetylcysteine—Somnolence—Paclitaxel—breast cancer	0.000129	0.000742	CcSEcCtD
Acetylcysteine—Loss of consciousness—Capecitabine—breast cancer	0.000128	0.000738	CcSEcCtD
Acetylcysteine—Nausea—Vinorelbine—breast cancer	0.000128	0.000737	CcSEcCtD
Acetylcysteine—Dyspepsia—Paclitaxel—breast cancer	0.000127	0.000735	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000127	0.000733	CcSEcCtD
Acetylcysteine—Cough—Capecitabine—breast cancer	0.000127	0.000733	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—breast cancer	0.000127	0.00073	CcSEcCtD
Acetylcysteine—Hypersensitivity—Fluorouracil—breast cancer	0.000125	0.000722	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000125	0.000721	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—breast cancer	0.000124	0.000718	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—breast cancer	0.000124	0.000713	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000123	0.00071	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Docetaxel—breast cancer	0.000123	0.000708	CcSEcCtD
Acetylcysteine—Oedema—Docetaxel—breast cancer	0.000123	0.000708	CcSEcCtD
Acetylcysteine—Pruritus—Gemcitabine—breast cancer	0.000122	0.000706	CcSEcCtD
Acetylcysteine—Nausea—Thiotepa—breast cancer	0.000122	0.000704	CcSEcCtD
Acetylcysteine—Shock—Docetaxel—breast cancer	0.000121	0.000696	CcSEcCtD
Acetylcysteine—Pruritus—Fluorouracil—breast cancer	0.00012	0.000694	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—breast cancer	0.00012	0.000693	CcSEcCtD
Acetylcysteine—Tachycardia—Docetaxel—breast cancer	0.00012	0.000691	CcSEcCtD
Acetylcysteine—Skin disorder—Docetaxel—breast cancer	0.000119	0.000687	CcSEcCtD
Acetylcysteine—Oedema—Capecitabine—breast cancer	0.000119	0.000685	CcSEcCtD
Acetylcysteine—Dizziness—Irinotecan—breast cancer	0.000117	0.000677	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—breast cancer	0.000117	0.000675	CcSEcCtD
Acetylcysteine—Shock—Capecitabine—breast cancer	0.000117	0.000674	CcSEcCtD
Acetylcysteine—Tachycardia—Capecitabine—breast cancer	0.000116	0.000669	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—breast cancer	0.000116	0.000667	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—breast cancer	0.000116	0.000666	CcSEcCtD
Acetylcysteine—Skin disorder—Capecitabine—breast cancer	0.000115	0.000666	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—breast cancer	0.000115	0.000664	CcSEcCtD
Acetylcysteine—Urticaria—Paclitaxel—breast cancer	0.000115	0.000663	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Capecitabine—breast cancer	0.000115	0.000662	CcSEcCtD
Acetylcysteine—Hypotension—Docetaxel—breast cancer	0.000115	0.000661	CcSEcCtD
Acetylcysteine—Body temperature increased—Paclitaxel—breast cancer	0.000114	0.00066	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—breast cancer	0.000113	0.000651	CcSEcCtD
Acetylcysteine—Vomiting—Irinotecan—breast cancer	0.000113	0.000651	CcSEcCtD
Acetylcysteine—Vomiting—Mitoxantrone—breast cancer	0.000113	0.000651	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—breast cancer	0.000112	0.000649	CcSEcCtD
Acetylcysteine—Dizziness—Fluorouracil—breast cancer	0.000112	0.000648	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—breast cancer	0.000112	0.000647	CcSEcCtD
Acetylcysteine—Rash—Mitoxantrone—breast cancer	0.000112	0.000646	CcSEcCtD
Acetylcysteine—Rash—Irinotecan—breast cancer	0.000112	0.000646	CcSEcCtD
Acetylcysteine—Dermatitis—Mitoxantrone—breast cancer	0.000112	0.000645	CcSEcCtD
Acetylcysteine—Dermatitis—Irinotecan—breast cancer	0.000112	0.000645	CcSEcCtD
Acetylcysteine—Hypotension—Capecitabine—breast cancer	0.000111	0.00064	CcSEcCtD
Acetylcysteine—Vomiting—Gemcitabine—breast cancer	0.00011	0.000634	CcSEcCtD
Acetylcysteine—Dyspnoea—Docetaxel—breast cancer	0.000109	0.000631	CcSEcCtD
Acetylcysteine—Somnolence—Docetaxel—breast cancer	0.000109	0.000629	CcSEcCtD
Acetylcysteine—Rash—Gemcitabine—breast cancer	0.000109	0.000629	CcSEcCtD
Acetylcysteine—Dermatitis—Gemcitabine—breast cancer	0.000109	0.000628	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—breast cancer	0.000108	0.000625	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—breast cancer	0.000108	0.000624	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—breast cancer	0.000108	0.000624	CcSEcCtD
Acetylcysteine—Vomiting—Fluorouracil—breast cancer	0.000108	0.000623	CcSEcCtD
Acetylcysteine—Dyspepsia—Docetaxel—breast cancer	0.000108	0.000623	CcSEcCtD
Acetylcysteine—Rash—Fluorouracil—breast cancer	0.000107	0.000618	CcSEcCtD
Acetylcysteine—Dermatitis—Fluorouracil—breast cancer	0.000107	0.000618	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—breast cancer	0.000107	0.000617	CcSEcCtD
Acetylcysteine—Hypersensitivity—Paclitaxel—breast cancer	0.000107	0.000615	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000106	0.000611	CcSEcCtD
Acetylcysteine—Dyspnoea—Capecitabine—breast cancer	0.000106	0.000611	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—breast cancer	0.000106	0.00061	CcSEcCtD
Acetylcysteine—Nausea—Irinotecan—breast cancer	0.000105	0.000608	CcSEcCtD
Acetylcysteine—Nausea—Mitoxantrone—breast cancer	0.000105	0.000608	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—breast cancer	0.000105	0.000607	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—breast cancer	0.000105	0.000606	CcSEcCtD
Acetylcysteine—Dyspepsia—Capecitabine—breast cancer	0.000105	0.000603	CcSEcCtD
Acetylcysteine—Nausea—Gemcitabine—breast cancer	0.000103	0.000592	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Capecitabine—breast cancer	0.000103	0.000592	CcSEcCtD
Acetylcysteine—Pruritus—Paclitaxel—breast cancer	0.000102	0.000591	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—breast cancer	0.000101	0.000585	CcSEcCtD
Acetylcysteine—Nausea—Fluorouracil—breast cancer	0.000101	0.000582	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—breast cancer	0.0001	0.000577	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—breast cancer	0.0001	0.000577	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—breast cancer	9.78e-05	0.000564	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—breast cancer	9.74e-05	0.000562	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—breast cancer	9.72e-05	0.00056	CcSEcCtD
Acetylcysteine—Body temperature increased—Docetaxel—breast cancer	9.7e-05	0.000559	CcSEcCtD
Acetylcysteine—Dizziness—Paclitaxel—breast cancer	9.57e-05	0.000552	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—breast cancer	9.46e-05	0.000545	CcSEcCtD
Acetylcysteine—Urticaria—Capecitabine—breast cancer	9.44e-05	0.000544	CcSEcCtD
Acetylcysteine—Body temperature increased—Capecitabine—breast cancer	9.39e-05	0.000542	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—breast cancer	9.38e-05	0.000541	CcSEcCtD
Acetylcysteine—Vomiting—Paclitaxel—breast cancer	9.21e-05	0.000531	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	9.16e-05	0.000528	CcSEcCtD
Acetylcysteine—Rash—Paclitaxel—breast cancer	9.13e-05	0.000526	CcSEcCtD
Acetylcysteine—Dermatitis—Paclitaxel—breast cancer	9.12e-05	0.000526	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—breast cancer	9.1e-05	0.000525	CcSEcCtD
Acetylcysteine—Hypersensitivity—Docetaxel—breast cancer	9.04e-05	0.000521	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—breast cancer	8.91e-05	0.000514	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—breast cancer	8.85e-05	0.00051	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—breast cancer	8.85e-05	0.00051	CcSEcCtD
Acetylcysteine—Hypersensitivity—Capecitabine—breast cancer	8.75e-05	0.000505	CcSEcCtD
Acetylcysteine—Pruritus—Docetaxel—breast cancer	8.68e-05	0.000501	CcSEcCtD
Acetylcysteine—Nausea—Paclitaxel—breast cancer	8.6e-05	0.000496	CcSEcCtD
Acetylcysteine—Skin disorder—Methotrexate—breast cancer	8.59e-05	0.000495	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.58e-05	0.000495	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—breast cancer	8.55e-05	0.000493	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—breast cancer	8.42e-05	0.000485	CcSEcCtD
Acetylcysteine—Pruritus—Capecitabine—breast cancer	8.41e-05	0.000485	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—breast cancer	8.28e-05	0.000477	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—breast cancer	8.28e-05	0.000477	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—breast cancer	8.27e-05	0.000477	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—breast cancer	8.25e-05	0.000476	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—breast cancer	8.19e-05	0.000472	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—breast cancer	8.14e-05	0.00047	CcSEcCtD
Acetylcysteine—Dizziness—Docetaxel—breast cancer	8.12e-05	0.000468	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—breast cancer	8.08e-05	0.000466	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—breast cancer	8.04e-05	0.000464	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—breast cancer	8e-05	0.000461	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.93e-05	0.000458	CcSEcCtD
Acetylcysteine—Dyspnoea—Methotrexate—breast cancer	7.89e-05	0.000455	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—breast cancer	7.86e-05	0.000453	CcSEcCtD
Acetylcysteine—Dizziness—Capecitabine—breast cancer	7.86e-05	0.000453	CcSEcCtD
Acetylcysteine—Vomiting—Docetaxel—breast cancer	7.8e-05	0.00045	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—breast cancer	7.79e-05	0.000449	CcSEcCtD
Acetylcysteine—Rash—Docetaxel—breast cancer	7.74e-05	0.000446	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—breast cancer	7.74e-05	0.000446	CcSEcCtD
Acetylcysteine—Dermatitis—Docetaxel—breast cancer	7.73e-05	0.000446	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—breast cancer	7.66e-05	0.000442	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—breast cancer	7.66e-05	0.000442	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—breast cancer	7.64e-05	0.00044	CcSEcCtD
Acetylcysteine—Vomiting—Capecitabine—breast cancer	7.55e-05	0.000436	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—breast cancer	7.54e-05	0.000435	CcSEcCtD
Acetylcysteine—Rash—Capecitabine—breast cancer	7.49e-05	0.000432	CcSEcCtD
Acetylcysteine—Dermatitis—Capecitabine—breast cancer	7.49e-05	0.000432	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—breast cancer	7.48e-05	0.000431	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—breast cancer	7.44e-05	0.000429	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—breast cancer	7.4e-05	0.000427	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—breast cancer	7.38e-05	0.000426	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—breast cancer	7.36e-05	0.000424	CcSEcCtD
Acetylcysteine—Nausea—Docetaxel—breast cancer	7.29e-05	0.00042	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—breast cancer	7.29e-05	0.00042	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—breast cancer	7.16e-05	0.000413	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—breast cancer	7.15e-05	0.000412	CcSEcCtD
Acetylcysteine—Nausea—Capecitabine—breast cancer	7.06e-05	0.000407	CcSEcCtD
Acetylcysteine—Urticaria—Methotrexate—breast cancer	7.03e-05	0.000405	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—breast cancer	6.99e-05	0.000403	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—breast cancer	6.83e-05	0.000394	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—breast cancer	6.81e-05	0.000393	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—breast cancer	6.74e-05	0.000389	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—breast cancer	6.61e-05	0.000381	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—breast cancer	6.58e-05	0.000379	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—breast cancer	6.54e-05	0.000377	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methotrexate—breast cancer	6.52e-05	0.000376	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—breast cancer	6.26e-05	0.000361	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—breast cancer	6.1e-05	0.000352	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—breast cancer	6.08e-05	0.000351	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—breast cancer	6.05e-05	0.000349	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—breast cancer	5.86e-05	0.000338	CcSEcCtD
Acetylcysteine—Dizziness—Methotrexate—breast cancer	5.85e-05	0.000337	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—breast cancer	5.64e-05	0.000325	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—breast cancer	5.62e-05	0.000324	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—breast cancer	5.58e-05	0.000322	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—breast cancer	5.57e-05	0.000321	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—breast cancer	5.47e-05	0.000316	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—breast cancer	5.42e-05	0.000313	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—breast cancer	5.26e-05	0.000304	CcSEcCtD
Acetylcysteine—Nausea—Methotrexate—breast cancer	5.25e-05	0.000303	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—breast cancer	5.22e-05	0.000301	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—breast cancer	5.21e-05	0.000301	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—breast cancer	5.06e-05	0.000292	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—breast cancer	4.92e-05	0.000284	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—breast cancer	4.87e-05	0.000281	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—breast cancer	4.83e-05	0.000279	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—breast cancer	4.82e-05	0.000278	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—breast cancer	4.55e-05	0.000262	CcSEcCtD
Acetylcysteine—SLCO1B1—Metabolism—PLA2G4A—breast cancer	4.76e-06	2.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—breast cancer	4.75e-06	2.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFA—breast cancer	4.75e-06	2.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NCOR1—breast cancer	4.74e-06	2.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PLA2G4A—breast cancer	4.74e-06	2.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BRAF—breast cancer	4.73e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FOS—breast cancer	4.71e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGF1—breast cancer	4.69e-06	2.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CSF2—breast cancer	4.69e-06	2.05e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFBR2—breast cancer	4.68e-06	2.04e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRG1—breast cancer	4.65e-06	2.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—H2AFX—breast cancer	4.62e-06	2.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ITPR1—breast cancer	4.6e-06	2.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT2—breast cancer	4.6e-06	2.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CASP8—breast cancer	4.6e-06	2.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—E2F1—breast cancer	4.59e-06	2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT5A—breast cancer	4.57e-06	2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB4—breast cancer	4.57e-06	2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP3—breast cancer	4.57e-06	2e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—breast cancer	4.57e-06	1.99e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—breast cancer	4.56e-06	1.99e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GPX1—breast cancer	4.56e-06	1.99e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—breast cancer	4.55e-06	1.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT2—breast cancer	4.52e-06	1.97e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP1A1—breast cancer	4.51e-06	1.97e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ERCC2—breast cancer	4.47e-06	1.95e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—breast cancer	4.43e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SMAD4—breast cancer	4.43e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CD—breast cancer	4.42e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SPP1—breast cancer	4.41e-06	1.93e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1R—breast cancer	4.4e-06	1.92e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—breast cancer	4.38e-06	1.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SERPINE1—breast cancer	4.37e-06	1.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—breast cancer	4.37e-06	1.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB3—breast cancer	4.36e-06	1.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR2—breast cancer	4.35e-06	1.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2—breast cancer	4.35e-06	1.9e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CD—breast cancer	4.34e-06	1.9e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HES1—breast cancer	4.32e-06	1.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNG—breast cancer	4.31e-06	1.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—breast cancer	4.31e-06	1.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PLA2G4A—breast cancer	4.3e-06	1.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NCOR1—breast cancer	4.3e-06	1.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MDM2—breast cancer	4.29e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—RAF1—breast cancer	4.27e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—RELA—breast cancer	4.26e-06	1.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CSF2—breast cancer	4.25e-06	1.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGF1—breast cancer	4.25e-06	1.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ERBB2—breast cancer	4.23e-06	1.85e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRG1—breast cancer	4.22e-06	1.84e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—breast cancer	4.2e-06	1.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—breast cancer	4.19e-06	1.83e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—H2AFX—breast cancer	4.19e-06	1.83e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—breast cancer	4.18e-06	1.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS3—breast cancer	4.17e-06	1.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CB—breast cancer	4.17e-06	1.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MTOR—breast cancer	4.17e-06	1.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD4—breast cancer	4.17e-06	1.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—E2F1—breast cancer	4.16e-06	1.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—breast cancer	4.14e-06	1.81e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR1—breast cancer	4.06e-06	1.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—breast cancer	4.04e-06	1.76e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SPP1—breast cancer	4e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HIF1A—breast cancer	4e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—breast cancer	3.96e-06	1.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MDM2—breast cancer	3.96e-06	1.73e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB3—breast cancer	3.95e-06	1.73e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR2—breast cancer	3.95e-06	1.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2—breast cancer	3.95e-06	1.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—RAF1—breast cancer	3.95e-06	1.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1B—breast cancer	3.92e-06	1.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNG—breast cancer	3.91e-06	1.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERBB2—breast cancer	3.9e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LEP—breast cancer	3.9e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MDM2—breast cancer	3.89e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—breast cancer	3.88e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAV1—breast cancer	3.88e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—RAF1—breast cancer	3.88e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—breast cancer	3.87e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CAV1—breast cancer	3.87e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—RELA—breast cancer	3.86e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CB—breast cancer	3.85e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTOR—breast cancer	3.85e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1B—breast cancer	3.85e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CD4—breast cancer	3.85e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ERBB2—breast cancer	3.83e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—breast cancer	3.83e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KDR—breast cancer	3.82e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—breast cancer	3.82e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—breast cancer	3.8e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—breast cancer	3.79e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CB—breast cancer	3.78e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MTOR—breast cancer	3.78e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD4—breast cancer	3.78e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JUN—breast cancer	3.73e-06	1.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—breast cancer	3.73e-06	1.63e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.7e-06	1.62e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTNNB1—breast cancer	3.7e-06	1.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR1—breast cancer	3.68e-06	1.61e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FN1—breast cancer	3.68e-06	1.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—breast cancer	3.66e-06	1.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NFKBIA—breast cancer	3.64e-06	1.59e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HIF1A—breast cancer	3.62e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1B—breast cancer	3.62e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1A—breast cancer	3.61e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—breast cancer	3.61e-06	1.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOTCH1—breast cancer	3.6e-06	1.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—breast cancer	3.57e-06	1.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1B—breast cancer	3.55e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LEP—breast cancer	3.54e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CG—breast cancer	3.53e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK8—breast cancer	3.53e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CG—breast cancer	3.52e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APC—breast cancer	3.52e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KIT—breast cancer	3.52e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—breast cancer	3.52e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—breast cancer	3.51e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CAV1—breast cancer	3.51e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1B—breast cancer	3.49e-06	1.52e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGF—breast cancer	3.48e-06	1.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—breast cancer	3.48e-06	1.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KDR—breast cancer	3.47e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—breast cancer	3.43e-06	1.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CTNNB1—breast cancer	3.42e-06	1.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JUN—breast cancer	3.38e-06	1.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—breast cancer	3.38e-06	1.47e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTNNB1—breast cancer	3.36e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—breast cancer	3.34e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1A—breast cancer	3.34e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FN1—breast cancer	3.34e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—breast cancer	3.33e-06	1.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BRAF—breast cancer	3.31e-06	1.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NFKBIA—breast cancer	3.3e-06	1.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1A—breast cancer	3.28e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—breast cancer	3.27e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOTCH1—breast cancer	3.27e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—breast cancer	3.24e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—breast cancer	3.23e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1—breast cancer	3.22e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT2—breast cancer	3.22e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK8—breast cancer	3.2e-06	1.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CG—breast cancer	3.19e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KIT—breast cancer	3.19e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APC—breast cancer	3.19e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGF—breast cancer	3.16e-06	1.38e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—breast cancer	3.11e-06	1.36e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CD—breast cancer	3.11e-06	1.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CD—breast cancer	3.1e-06	1.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—breast cancer	3.09e-06	1.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK3—breast cancer	3.08e-06	1.35e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALB—breast cancer	3.07e-06	1.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SERPINE1—breast cancer	3.06e-06	1.34e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—breast cancer	3.03e-06	1.32e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BRAF—breast cancer	3e-06	1.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—breast cancer	2.98e-06	1.3e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NOS3—breast cancer	2.93e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—breast cancer	2.93e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—breast cancer	2.92e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1—breast cancer	2.92e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOS3—breast cancer	2.92e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT2—breast cancer	2.92e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAPK3—breast cancer	2.84e-06	1.24e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CD—breast cancer	2.81e-06	1.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK3—breast cancer	2.79e-06	1.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SERPINE1—breast cancer	2.78e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MDM2—breast cancer	2.77e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—breast cancer	2.77e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—breast cancer	2.77e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RAF1—breast cancer	2.76e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—breast cancer	2.76e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RELA—breast cancer	2.75e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB2—breast cancer	2.73e-06	1.19e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CB—breast cancer	2.71e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—breast cancer	2.71e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MTOR—breast cancer	2.7e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CB—breast cancer	2.7e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—breast cancer	2.68e-06	1.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—breast cancer	2.66e-06	1.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOS3—breast cancer	2.65e-06	1.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—breast cancer	2.59e-06	1.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—breast cancer	2.56e-06	1.12e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—breast cancer	2.54e-06	1.11e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1B—breast cancer	2.53e-06	1.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MDM2—breast cancer	2.51e-06	1.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—breast cancer	2.51e-06	1.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RAF1—breast cancer	2.51e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RELA—breast cancer	2.49e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—breast cancer	2.48e-06	1.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB2—breast cancer	2.48e-06	1.08e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—breast cancer	2.48e-06	1.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MTOR—breast cancer	2.45e-06	1.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CB—breast cancer	2.45e-06	1.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—breast cancer	2.42e-06	1.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUN—breast cancer	2.41e-06	1.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CTNNB1—breast cancer	2.39e-06	1.04e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—breast cancer	2.35e-06	1.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—breast cancer	2.35e-06	1.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—breast cancer	2.35e-06	1.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—breast cancer	2.35e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—breast cancer	2.34e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1A—breast cancer	2.34e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—breast cancer	2.33e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—breast cancer	2.31e-06	1.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1B—breast cancer	2.3e-06	1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK8—breast cancer	2.28e-06	9.96e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—breast cancer	2.25e-06	9.84e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—breast cancer	2.25e-06	9.83e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—breast cancer	2.25e-06	9.81e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—breast cancer	2.19e-06	9.56e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUN—breast cancer	2.19e-06	9.54e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—breast cancer	2.17e-06	9.49e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CTNNB1—breast cancer	2.17e-06	9.47e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—breast cancer	2.16e-06	9.44e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—breast cancer	2.13e-06	9.32e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—breast cancer	2.13e-06	9.29e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1A—breast cancer	2.12e-06	9.25e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—breast cancer	2.11e-06	9.23e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—breast cancer	2.11e-06	9.2e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—breast cancer	2.09e-06	9.1e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—breast cancer	2.08e-06	9.08e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—breast cancer	2.08e-06	9.07e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK8—breast cancer	2.07e-06	9.03e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—breast cancer	2.04e-06	8.92e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK3—breast cancer	1.99e-06	8.7e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—breast cancer	1.96e-06	8.56e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—breast cancer	1.94e-06	8.46e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—breast cancer	1.93e-06	8.44e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—breast cancer	1.92e-06	8.38e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—breast cancer	1.91e-06	8.34e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—breast cancer	1.9e-06	8.27e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—breast cancer	1.89e-06	8.26e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—breast cancer	1.88e-06	8.23e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK3—breast cancer	1.81e-06	7.89e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—breast cancer	1.79e-06	7.82e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—breast cancer	1.76e-06	7.67e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—breast cancer	1.75e-06	7.65e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—breast cancer	1.72e-06	7.5e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.65e-06	7.2e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—breast cancer	1.64e-06	7.18e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—breast cancer	1.62e-06	7.09e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—breast cancer	1.59e-06	6.95e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—breast cancer	1.52e-06	6.64e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—breast cancer	1.49e-06	6.51e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—breast cancer	1.46e-06	6.36e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—breast cancer	1.44e-06	6.3e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—breast cancer	1.38e-06	6.03e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—breast cancer	1.35e-06	5.89e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—breast cancer	1.34e-06	5.87e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—breast cancer	1.32e-06	5.77e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—breast cancer	1.22e-06	5.32e-06	CbGpPWpGaD
